NRD
AGL icon

Nebula Research & Development’s Agilon Health AGL Stock Holding History

Nebula Research & Development’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,184
Closed -$215K – 882
2024
Q3 		$215K Buy
+2,184
New +$282K 0.03% 808

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nebula Research & Development's AGL Position: Q4 2024 in Review

Nebula Research & Development sold out of Agilon Health (AGL) in Q4 2024, closing a stake of 2,184 shares — an estimated $215K sold.

Nebula Research & Development first reported a position in AGL in Q3 2024 and held it in 1 quarter. The position peaked at $215K in Q3 2024. 184 funds tracked by Wall St. Rank hold AGL as of Q4 2024.

  • Nebula Research & Development reported no remaining Agilon Health position as of Q4 2024 after selling out during the quarter.
  • Nebula Research & Development sold 2,184 Agilon Health shares in Q4 2024, an estimated $215K.
  • Nebula Research & Development first reported a position in Agilon Health in Q3 2024 and held it in 1 quarter.
  • Nebula Research & Development's Agilon Health position peaked at $215K in Q3 2024.
  • 184 funds tracked by Wall St. Rank held Agilon Health as of Q4 2024.

Based on Nebula Research & Development's 13F filing for Q4 2024, filed 14 Feb 2025.